LANP mediates neuritic pathology in Spinocerebellar ataxia type 1

被引:19
|
作者
Cvetanovic, Marija [1 ]
Kular, Rupinder K. [1 ]
Opal, Puneet [1 ,2 ]
机构
[1] Northwestern Univ, Feinberg Sch Med, Davee Dept Neurol, Chicago, IL 60611 USA
[2] Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA
基金
美国国家卫生研究院;
关键词
LANP; pp32; ANP32-A; Spinocerebellar ataxia type 1; SCA1; Neurite outgrowth; CREB-BINDING PROTEIN; SCA1 TRANSGENIC MICE; HUNTINGTONS-DISEASE; REPRESSES TRANSCRIPTION; HISTONE ACETYLATION; GROWTH-FACTOR; CAG REPEAT; TRINUCLEOTIDE REPEAT; GENE-PRODUCT; MOUSE MODEL;
D O I
10.1016/j.nbd.2012.07.024
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Spinocerebellar ataxia type 1 (SCA1) is an autosomal dominant neurodegenerative disease that results from a pathogenic glutamine-repeat expansion in the protein ataxin-1 (ATXN1). Although the functions of ATXN1 are still largely unknown, there is evidence to suggest that ATXN1 plays a role in regulating gene expression, the earliest process known to go awry in SCA1 mouse models. In this study, we show that ATXN1 reduces histone acetylation, a post-translational modification of histones associated with enhanced transcription, and represses histone acetyl transferase-mediated transcription. In addition, we find that depleting the Leucine-rich Acidic Nuclear Protein (LANP)-an ATXN1 binding inhibitor of histone acetylation-reverses aspects of SCA1 neuritic pathology. (c) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码:526 / 532
页数:7
相关论文
共 50 条
  • [31] Fatigue is frequent and severe in spinocerebellar ataxia type 1
    Martins, Carlos R., Jr.
    Martinez, Alberto R. M.
    D'Abreu, Anelyssa
    Lopes-Cendes, Iscia
    Franca, Marcondes C., Jr.
    PARKINSONISM & RELATED DISORDERS, 2015, 21 (07) : 821 - 822
  • [32] Pigmentary macular dystrophy in spinocerebellar ataxia type 1
    Saito, Y.
    Matsumura, K.
    Shimizu, S.
    Ichikawa, Y.
    Ochiai, K.
    Goto, J.
    Tsuji, S.
    Shimizu, T.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2006, 77 (11): : 1293 - 1293
  • [33] Prevalence of Spinocerebellar ataxia type 1 in Yakutia (Russia)
    Fedorov, Afanasy I.
    Sukhomyasova, Aitalina L.
    Nikolaeva, Irina A.
    Maksimova, Anastasia A.
    Ivanov, Aiaan V.
    Golikova, Polina I.
    Maksimova, Nadezhda R.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2022, 30 (SUPPL 1) : 298 - 298
  • [34] Neurochemical Differences in Spinocerebellar Ataxia Type 14 and 1
    Grosch, Anne Sophie
    Rinnenthal, Jan Leo
    Roennefarth, Maria
    Lux, Silke
    Scheel, Michael
    Endres, Matthias
    Brandt, Alexander U.
    Paul, Friedemann
    Schmitz-Huebsch, Tanja
    Minnerop, Martina
    Doss, Sarah
    CEREBELLUM, 2021, 20 (02): : 169 - 178
  • [35] Molecular pathogenesis of spinocerebellar ataxia type 1 disease
    Kang, Seongman
    Hong, Sunghoi
    MOLECULES AND CELLS, 2009, 27 (06) : 621 - 627
  • [36] Spinocerebellar Ataxia Type 2
    Scoles, Daniel R.
    Pulst, Stefan M.
    POLYGLUTAMINE DISORDERS, 2018, 1049 : 175 - 195
  • [37] Spinocerebellar ataxia type 15
    Gardner, RJM
    Knight, MA
    Hara, K
    Tsuji, S
    Forrest, SM
    Storey, E
    CEREBELLUM, 2005, 4 (01): : 47 - 50
  • [38] Spinocerebellar ataxia type 15
    R. J. Mckinlay Gardner
    Melanie A. Knight
    Kenju Hara
    Shoji Tsuji
    Susan M. Forrest
    Elsdon Storey
    The Cerebellum, 2005, 4 : 47 - 50
  • [39] Spinocerebellar Ataxia Type 2
    Pulst, Stefan M.
    NEUROLOGY-GENETICS, 2025, 11 (01)
  • [40] Spinocerebellar ataxia type 20
    Storey, E
    Knight, MA
    Forrest, SM
    Gardner, RJM
    CEREBELLUM, 2005, 4 (01): : 55 - 57